NMPA Accepts Sichuan Kelun-Biotech’s SAC-TMT New Indication Application
China’s National Medical Products Administration accepted a new indication application for SAC-TMT, according to Sichuan Kelun-Biotech.
Related stories
Gulf International Services Reports Q3 Revenue of 1.22 Billion Riyals
M impact | EQUITY | Oct 29, 2026, 01:43 PM UTC
Allied Properties REIT Shares Drop 25% After Q3 Rental Revenue Falls
M impact | EQUITY | Oct 29, 2026, 01:42 PM UTC
Sanan Optoelectronics Reports Q3 Net Loss of 22.5 Million Yuan
M impact | EQUITY | Oct 29, 2026, 01:42 PM UTC
Positron Energy Awarded Tender Valued at 240 Million Rupees
M impact | EQUITY | Oct 29, 2026, 01:42 PM UTC
Gulf International Services Q3 Net Profit 78 Million Riyals
M impact | EQUITY | Oct 29, 2026, 01:41 PM UTC
Hershey Shares Fall 2% as Company Warns of Halloween Consumer Pressure
Hershey shares are down 2% after the company warned of consumer pressure during Halloween.
M impact | EQUITY | Oct 29, 2026, 01:41 PM UTC